Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 12 | 2016 | 1196 | 2.150 |
Why?
|
Stroke Volume | 6 | 2016 | 452 | 1.520 |
Why?
|
Myocardial Infarction | 7 | 2009 | 372 | 1.260 |
Why?
|
Anti-Arrhythmia Agents | 5 | 2012 | 58 | 1.100 |
Why?
|
Adrenergic beta-Antagonists | 4 | 2012 | 152 | 1.010 |
Why?
|
Antihypertensive Agents | 6 | 2011 | 521 | 1.010 |
Why?
|
Aspirin | 3 | 2008 | 156 | 0.910 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2009 | 66 | 0.890 |
Why?
|
Acute Coronary Syndrome | 3 | 2013 | 45 | 0.860 |
Why?
|
Hospitalization | 5 | 2016 | 844 | 0.830 |
Why?
|
Hypertension | 6 | 2011 | 1139 | 0.750 |
Why?
|
Heart Rate | 3 | 2012 | 492 | 0.690 |
Why?
|
Ticlopidine | 2 | 2009 | 25 | 0.680 |
Why?
|
Humans | 66 | 2016 | 86281 | 0.660 |
Why?
|
Quality of Health Care | 3 | 2011 | 380 | 0.660 |
Why?
|
Long QT Syndrome | 2 | 2008 | 34 | 0.650 |
Why?
|
Hospital Mortality | 3 | 2016 | 347 | 0.640 |
Why?
|
Postprandial Period | 2 | 2008 | 47 | 0.640 |
Why?
|
Potassium | 2 | 2009 | 281 | 0.620 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2009 | 132 | 0.610 |
Why?
|
Anticoagulants | 2 | 2013 | 404 | 0.610 |
Why?
|
Hyperglycemia | 2 | 2008 | 176 | 0.580 |
Why?
|
Coronary Vessels | 2 | 2009 | 174 | 0.580 |
Why?
|
Heart | 2 | 2009 | 538 | 0.570 |
Why?
|
Coronary Artery Disease | 4 | 2011 | 347 | 0.560 |
Why?
|
Stents | 2 | 2009 | 375 | 0.550 |
Why?
|
Secondary Prevention | 3 | 2013 | 162 | 0.540 |
Why?
|
Length of Stay | 2 | 2016 | 697 | 0.510 |
Why?
|
Atrial Fibrillation | 2 | 2008 | 280 | 0.500 |
Why?
|
Sepsis | 2 | 2008 | 304 | 0.500 |
Why?
|
Arrhythmias, Cardiac | 3 | 2016 | 187 | 0.480 |
Why?
|
Cardiovascular Diseases | 3 | 2009 | 826 | 0.450 |
Why?
|
Amiodarone | 2 | 2008 | 12 | 0.400 |
Why?
|
Medically Uninsured | 1 | 2011 | 58 | 0.400 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 59 | 0.400 |
Why?
|
Ventricular Function, Left | 3 | 2010 | 589 | 0.400 |
Why?
|
Tachycardia | 2 | 2012 | 35 | 0.390 |
Why?
|
Vasopressins | 2 | 2001 | 49 | 0.390 |
Why?
|
Aged | 17 | 2016 | 18353 | 0.370 |
Why?
|
Oxytocin | 2 | 2001 | 71 | 0.370 |
Why?
|
Coronary Disease | 2 | 2008 | 261 | 0.360 |
Why?
|
Pericardial Effusion | 1 | 2009 | 19 | 0.360 |
Why?
|
Carotid Sinus | 1 | 2009 | 24 | 0.360 |
Why?
|
Heart Failure, Systolic | 1 | 2009 | 7 | 0.360 |
Why?
|
Electrocardiography | 2 | 2009 | 478 | 0.360 |
Why?
|
Stroke | 6 | 2011 | 959 | 0.360 |
Why?
|
Atenolol | 1 | 2009 | 34 | 0.360 |
Why?
|
Coronary Artery Bypass | 2 | 2008 | 228 | 0.360 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2010 | 318 | 0.350 |
Why?
|
Syncope | 1 | 2009 | 34 | 0.350 |
Why?
|
Scleroderma, Systemic | 1 | 2009 | 43 | 0.350 |
Why?
|
Proton Pump Inhibitors | 1 | 2009 | 31 | 0.340 |
Why?
|
Myocarditis | 1 | 2009 | 50 | 0.340 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2008 | 40 | 0.340 |
Why?
|
Naproxen | 1 | 2008 | 13 | 0.340 |
Why?
|
Prostaglandins | 1 | 2008 | 42 | 0.340 |
Why?
|
Protease Inhibitors | 1 | 2009 | 72 | 0.340 |
Why?
|
Prognosis | 8 | 2012 | 3669 | 0.340 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 112 | 0.330 |
Why?
|
Hypoglycemia | 1 | 2009 | 106 | 0.330 |
Why?
|
Syncope, Vasovagal | 1 | 2008 | 3 | 0.330 |
Why?
|
Cause of Death | 1 | 2010 | 277 | 0.330 |
Why?
|
Ganglionectomy | 1 | 2008 | 2 | 0.330 |
Why?
|
Propanolamines | 1 | 2008 | 36 | 0.330 |
Why?
|
Propranolol | 1 | 2008 | 45 | 0.330 |
Why?
|
Myoglobin | 1 | 2008 | 29 | 0.320 |
Why?
|
Fingers | 1 | 2008 | 68 | 0.320 |
Why?
|
Inpatients | 1 | 2011 | 295 | 0.320 |
Why?
|
Atherosclerosis | 2 | 2008 | 243 | 0.320 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2008 | 11 | 0.320 |
Why?
|
Creatine Kinase | 1 | 2008 | 52 | 0.320 |
Why?
|
Endarterectomy, Carotid | 1 | 2008 | 73 | 0.320 |
Why?
|
Aged, 80 and over | 8 | 2016 | 6481 | 0.320 |
Why?
|
Clostridium perfringens | 1 | 2007 | 7 | 0.320 |
Why?
|
Troponin I | 1 | 2008 | 26 | 0.320 |
Why?
|
Blood Pressure | 5 | 2011 | 1143 | 0.320 |
Why?
|
Umbilicus | 1 | 2007 | 5 | 0.320 |
Why?
|
Vascular Malformations | 1 | 2008 | 19 | 0.320 |
Why?
|
Medicare | 1 | 2011 | 404 | 0.320 |
Why?
|
Atrioventricular Node | 1 | 2008 | 33 | 0.320 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2007 | 8 | 0.320 |
Why?
|
Radiation Injuries | 1 | 2009 | 155 | 0.310 |
Why?
|
Echocardiography | 2 | 2010 | 911 | 0.310 |
Why?
|
Aortic Valve Stenosis | 1 | 2009 | 129 | 0.310 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2008 | 44 | 0.310 |
Why?
|
Thiazolidinediones | 1 | 2008 | 82 | 0.310 |
Why?
|
Hypertriglyceridemia | 1 | 2008 | 67 | 0.310 |
Why?
|
Natriuretic Agents | 1 | 2007 | 2 | 0.310 |
Why?
|
Coronary Vasospasm | 1 | 2007 | 12 | 0.310 |
Why?
|
Female | 24 | 2016 | 44405 | 0.310 |
Why?
|
Carotid Stenosis | 1 | 2008 | 112 | 0.310 |
Why?
|
Dyslipidemias | 1 | 2009 | 109 | 0.310 |
Why?
|
Hyperlipidemias | 1 | 2008 | 95 | 0.310 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 208 | 0.310 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 298 | 0.310 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 90 | 0.310 |
Why?
|
Pulmonary Veins | 1 | 2008 | 72 | 0.300 |
Why?
|
Risk Assessment | 6 | 2010 | 2253 | 0.300 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 129 | 0.300 |
Why?
|
Cocaine | 1 | 2008 | 76 | 0.300 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2007 | 56 | 0.300 |
Why?
|
Male | 23 | 2016 | 40860 | 0.300 |
Why?
|
Clostridium Infections | 2 | 2014 | 125 | 0.300 |
Why?
|
Mitral Valve | 1 | 2009 | 247 | 0.290 |
Why?
|
Bretylium Compounds | 1 | 2006 | 1 | 0.290 |
Why?
|
Ischemia | 1 | 2008 | 242 | 0.290 |
Why?
|
Mitral Valve Insufficiency | 1 | 2009 | 187 | 0.290 |
Why?
|
Clindamycin | 1 | 2006 | 13 | 0.290 |
Why?
|
Critical Illness | 1 | 2009 | 293 | 0.290 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2006 | 18 | 0.290 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 231 | 0.290 |
Why?
|
Diuretics | 1 | 2007 | 124 | 0.290 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 87 | 0.290 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 241 | 0.290 |
Why?
|
Referral and Consultation | 1 | 2009 | 326 | 0.290 |
Why?
|
Geriatric Assessment | 1 | 2007 | 166 | 0.280 |
Why?
|
Drug Eruptions | 1 | 2006 | 35 | 0.280 |
Why?
|
Ventricular Fibrillation | 1 | 2006 | 65 | 0.280 |
Why?
|
Vasodilator Agents | 1 | 2007 | 152 | 0.280 |
Why?
|
Body Mass Index | 1 | 2010 | 770 | 0.280 |
Why?
|
Critical Care | 1 | 2009 | 368 | 0.280 |
Why?
|
Prenatal Diagnosis | 1 | 2006 | 104 | 0.280 |
Why?
|
Drug Therapy, Combination | 4 | 2009 | 893 | 0.280 |
Why?
|
Adenosine Triphosphate | 3 | 2001 | 314 | 0.270 |
Why?
|
Thrombolytic Therapy | 1 | 2008 | 220 | 0.270 |
Why?
|
Melanoma | 1 | 2009 | 454 | 0.270 |
Why?
|
Patient Selection | 1 | 2009 | 685 | 0.260 |
Why?
|
Blood Glucose | 1 | 2009 | 873 | 0.260 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 377 | 0.260 |
Why?
|
Middle Aged | 16 | 2016 | 24957 | 0.250 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 266 | 0.250 |
Why?
|
Supraoptic Nucleus | 2 | 2001 | 2 | 0.250 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 345 | 0.250 |
Why?
|
Neuropeptide Y | 2 | 2001 | 31 | 0.250 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 206 | 0.250 |
Why?
|
Substance P | 2 | 2001 | 60 | 0.250 |
Why?
|
Heart Arrest | 1 | 2007 | 264 | 0.240 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2001 | 81 | 0.240 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 801 | 0.230 |
Why?
|
Pregnancy Complications | 1 | 2006 | 336 | 0.230 |
Why?
|
Psoriasis | 1 | 2006 | 239 | 0.230 |
Why?
|
Epidermal Cyst | 1 | 2003 | 7 | 0.230 |
Why?
|
Cardiac Surgical Procedures | 1 | 2008 | 461 | 0.230 |
Why?
|
Meningitis, Aseptic | 1 | 2003 | 8 | 0.230 |
Why?
|
Spinal Neoplasms | 1 | 2003 | 50 | 0.230 |
Why?
|
Obesity | 1 | 2010 | 962 | 0.220 |
Why?
|
Pituitary Gland, Posterior | 1 | 2001 | 3 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2010 | 850 | 0.210 |
Why?
|
Risk Factors | 8 | 2015 | 5397 | 0.200 |
Why?
|
Decision Making | 1 | 2007 | 641 | 0.200 |
Why?
|
Diagnosis, Differential | 5 | 2014 | 1562 | 0.200 |
Why?
|
Hydrocortisone | 1 | 2003 | 298 | 0.200 |
Why?
|
Neuropeptides | 1 | 2001 | 112 | 0.200 |
Why?
|
Purinergic Agonists | 1 | 2000 | 1 | 0.200 |
Why?
|
Adrenergic Agonists | 1 | 2000 | 2 | 0.200 |
Why?
|
Anti-Bacterial Agents | 1 | 2006 | 739 | 0.200 |
Why?
|
Pyridoxal Phosphate | 1 | 2000 | 13 | 0.200 |
Why?
|
Neurotransmitter Agents | 1 | 2001 | 106 | 0.200 |
Why?
|
Incidence | 3 | 2011 | 1568 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2007 | 1160 | 0.190 |
Why?
|
HIV Infections | 1 | 2009 | 768 | 0.190 |
Why?
|
Survival Rate | 3 | 2009 | 1856 | 0.180 |
Why?
|
Confidence Intervals | 2 | 2010 | 228 | 0.170 |
Why?
|
Treatment Outcome | 5 | 2011 | 7949 | 0.170 |
Why?
|
Brain Ischemia | 2 | 2015 | 397 | 0.170 |
Why?
|
Risk | 3 | 2010 | 673 | 0.170 |
Why?
|
Contraindications | 2 | 2009 | 71 | 0.170 |
Why?
|
Drug Interactions | 2 | 2009 | 248 | 0.160 |
Why?
|
Severity of Illness Index | 3 | 2010 | 1796 | 0.160 |
Why?
|
Postoperative Complications | 1 | 2008 | 2183 | 0.160 |
Why?
|
Systole | 2 | 2008 | 129 | 0.160 |
Why?
|
Fatal Outcome | 2 | 2009 | 293 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 2 | 2010 | 859 | 0.150 |
Why?
|
Phenylephrine | 3 | 2001 | 35 | 0.150 |
Why?
|
Survival Analysis | 3 | 2010 | 1536 | 0.150 |
Why?
|
Reference Values | 2 | 2008 | 673 | 0.150 |
Why?
|
Precipitating Factors | 1 | 2016 | 5 | 0.140 |
Why?
|
Norepinephrine | 3 | 2001 | 167 | 0.140 |
Why?
|
Ultrasonography | 2 | 2009 | 695 | 0.140 |
Why?
|
Adult | 7 | 2009 | 25577 | 0.140 |
Why?
|
Diarrhea | 2 | 2014 | 181 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 3347 | 0.140 |
Why?
|
Weight Gain | 1 | 2016 | 123 | 0.130 |
Why?
|
Brain Infarction | 1 | 2015 | 22 | 0.130 |
Why?
|
Pellagra | 1 | 2014 | 2 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 29 | 0.130 |
Why?
|
Medication Adherence | 1 | 2016 | 129 | 0.130 |
Why?
|
Dermatitis | 1 | 2014 | 32 | 0.130 |
Why?
|
Pneumonia | 1 | 2016 | 178 | 0.130 |
Why?
|
Cohort Studies | 2 | 2011 | 2759 | 0.120 |
Why?
|
Accidental Falls | 2 | 2011 | 50 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 1958 | 0.110 |
Why?
|
Prospective Studies | 2 | 2011 | 4194 | 0.110 |
Why?
|
Dementia | 1 | 2014 | 187 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2009 | 977 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2016 | 418 | 0.110 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 217 | 0.110 |
Why?
|
Hypotension, Orthostatic | 1 | 2011 | 5 | 0.110 |
Why?
|
Angina Pectoris | 2 | 2008 | 28 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2008 | 1680 | 0.100 |
Why?
|
Benzazepines | 1 | 2012 | 89 | 0.100 |
Why?
|
Time Factors | 3 | 2010 | 5198 | 0.100 |
Why?
|
Odds Ratio | 2 | 2010 | 677 | 0.100 |
Why?
|
Comorbidity | 2 | 2011 | 943 | 0.100 |
Why?
|
United States | 3 | 2011 | 6637 | 0.090 |
Why?
|
Drug Synergism | 2 | 2001 | 303 | 0.090 |
Why?
|
Life Expectancy | 1 | 2010 | 85 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2010 | 56 | 0.090 |
Why?
|
Cardiac Tamponade | 1 | 2009 | 17 | 0.090 |
Why?
|
Edema | 1 | 2009 | 70 | 0.090 |
Why?
|
Atrioventricular Block | 1 | 2009 | 23 | 0.090 |
Why?
|
California | 1 | 2009 | 138 | 0.090 |
Why?
|
Vipoma | 1 | 2009 | 4 | 0.090 |
Why?
|
Logistic Models | 2 | 2011 | 1184 | 0.090 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2009 | 15 | 0.090 |
Why?
|
Treatment Failure | 1 | 2009 | 284 | 0.090 |
Why?
|
Tablets, Enteric-Coated | 1 | 2008 | 6 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2009 | 105 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2009 | 45 | 0.080 |
Why?
|
Mediastinal Neoplasms | 1 | 2009 | 46 | 0.080 |
Why?
|
Probability | 1 | 2010 | 355 | 0.080 |
Why?
|
HIV | 1 | 2009 | 46 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2009 | 277 | 0.080 |
Why?
|
Echocardiography, Doppler | 1 | 2010 | 187 | 0.080 |
Why?
|
Diabetes Complications | 1 | 2010 | 206 | 0.080 |
Why?
|
Tilt-Table Test | 1 | 2008 | 4 | 0.080 |
Why?
|
Chylomicron Remnants | 1 | 2008 | 2 | 0.080 |
Why?
|
Metoprolol | 1 | 2008 | 30 | 0.080 |
Why?
|
Fibrosis | 1 | 2009 | 202 | 0.080 |
Why?
|
Platelet Activation | 1 | 2008 | 13 | 0.080 |
Why?
|
Glipizide | 1 | 2008 | 2 | 0.080 |
Why?
|
Cyclohexanes | 1 | 2008 | 9 | 0.080 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 44 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2009 | 128 | 0.080 |
Why?
|
Ventricular Premature Complexes | 1 | 2008 | 6 | 0.080 |
Why?
|
Age Factors | 2 | 2010 | 1842 | 0.080 |
Why?
|
Blood Platelets | 1 | 2008 | 149 | 0.080 |
Why?
|
Phenylalanine | 1 | 2008 | 37 | 0.080 |
Why?
|
Carbamates | 1 | 2008 | 19 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2009 | 160 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2001 | 1214 | 0.080 |
Why?
|
Sulfonylurea Compounds | 1 | 2008 | 64 | 0.080 |
Why?
|
Hemolysis | 1 | 2007 | 61 | 0.080 |
Why?
|
Registries | 1 | 2011 | 702 | 0.080 |
Why?
|
Drug Resistance | 1 | 2008 | 256 | 0.080 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 34 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2008 | 157 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2009 | 166 | 0.080 |
Why?
|
ROC Curve | 1 | 2010 | 752 | 0.080 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 857 | 0.080 |
Why?
|
Acute Disease | 1 | 2009 | 824 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2008 | 87 | 0.080 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2008 | 81 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2008 | 119 | 0.070 |
Why?
|
Administration, Oral | 1 | 2008 | 683 | 0.070 |
Why?
|
Exercise Test | 1 | 2008 | 164 | 0.070 |
Why?
|
Radiotherapy | 1 | 2009 | 326 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 916 | 0.070 |
Why?
|
Patient Readmission | 1 | 2010 | 324 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2006 | 70 | 0.070 |
Why?
|
Piperidines | 1 | 2008 | 181 | 0.070 |
Why?
|
Abnormalities, Multiple | 1 | 2008 | 232 | 0.070 |
Why?
|
Reoperation | 1 | 2008 | 589 | 0.070 |
Why?
|
Catheterization, Peripheral | 1 | 2006 | 58 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2009 | 373 | 0.070 |
Why?
|
Th1 Cells | 1 | 2007 | 164 | 0.070 |
Why?
|
Cyclosporine | 1 | 2006 | 234 | 0.070 |
Why?
|
Syndrome | 1 | 2006 | 446 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2008 | 377 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 200 | 0.070 |
Why?
|
Thrombosis | 1 | 2008 | 296 | 0.070 |
Why?
|
Cross Infection | 1 | 2006 | 141 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2007 | 444 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 378 | 0.060 |
Why?
|
Rats | 2 | 2001 | 3984 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2008 | 3616 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2008 | 1801 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 579 | 0.060 |
Why?
|
Recurrence | 1 | 2006 | 1137 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2009 | 705 | 0.060 |
Why?
|
Injections, Spinal | 1 | 2003 | 44 | 0.060 |
Why?
|
Therapeutic Irrigation | 1 | 2003 | 60 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 645 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 1168 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2009 | 731 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2003 | 362 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 2594 | 0.050 |
Why?
|
Biomarkers | 1 | 2008 | 1709 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 1376 | 0.050 |
Why?
|
Purinergic P2 Receptor Agonists | 1 | 2000 | 3 | 0.050 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2000 | 4 | 0.050 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2000 | 3 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2006 | 760 | 0.050 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2001 | 34 | 0.050 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 15 | 0.050 |
Why?
|
Culture Techniques | 1 | 2000 | 91 | 0.050 |
Why?
|
Maleimides | 1 | 2000 | 29 | 0.050 |
Why?
|
Pain | 2 | 2014 | 389 | 0.050 |
Why?
|
Signal Transduction | 2 | 2001 | 3233 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 286 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2000 | 270 | 0.040 |
Why?
|
Pregnancy | 1 | 2006 | 2885 | 0.040 |
Why?
|
Indoles | 1 | 2000 | 318 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2008 | 1372 | 0.040 |
Why?
|
Hemodynamics | 1 | 2001 | 710 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2000 | 632 | 0.040 |
Why?
|
Animals | 3 | 2001 | 26518 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2001 | 2810 | 0.030 |
Why?
|
Paresthesia | 1 | 2014 | 16 | 0.030 |
Why?
|
Polysomnography | 1 | 2015 | 150 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2014 | 85 | 0.030 |
Why?
|
Neurons | 1 | 2001 | 1545 | 0.030 |
Why?
|
Hepatitis C | 1 | 2014 | 208 | 0.030 |
Why?
|
Outpatients | 1 | 2011 | 94 | 0.020 |
Why?
|
Veterans | 1 | 2011 | 71 | 0.020 |
Why?
|
Hospitals, Veterans | 1 | 2010 | 17 | 0.020 |
Why?
|
United States Department of Veterans Affairs | 1 | 2010 | 26 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
Indium Radioisotopes | 1 | 2009 | 10 | 0.020 |
Why?
|
Octreotide | 1 | 2009 | 16 | 0.020 |
Why?
|
Hypokalemia | 1 | 2009 | 29 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 220 | 0.020 |
Why?
|
Irritable Bowel Syndrome | 1 | 2009 | 45 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 150 | 0.020 |
Why?
|
Monokines | 1 | 2007 | 3 | 0.020 |
Why?
|
Arteritis | 1 | 2007 | 9 | 0.020 |
Why?
|
Interleukin-18 | 1 | 2007 | 26 | 0.020 |
Why?
|
Lymphokines | 1 | 2007 | 76 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2007 | 125 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2007 | 108 | 0.020 |
Why?
|
Brain | 1 | 2015 | 2211 | 0.020 |
Why?
|
Liver | 1 | 2009 | 1229 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 775 | 0.010 |
Why?
|